Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I M Maisonneuve

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Brain Research|May 4, 2000
The potential anti-addictive agent, 18-methoxycoronaridine, blocks the sensitized locomotor and dopamine responses produced by repeated morphine treatmentK K Szumlinski, I M Maisonneuve, S D Glick
Toxicon : Official Journal of the International Society on Toxinology|August 11, 2000
Iboga interactions with psychomotor stimulants: panacea in the paradox?K K Szumlinski, I M Maisonneuve, S D Glick
Neuroreport|July 7, 2000
18-MC reduces methamphetamine and nicotine self-administration in ratsS D Glick, I M Maisonneuve, H A Dickinson
Drug and Alcohol Dependence|November 21, 2001
Biphasic dose-related effects of morphine on dopamine releaseI M Maisonneuve, L M Warner, S D Glick
Brain Research|October 21, 1996
Ibogaine neurotoxicity: a re-evaluationH H Molinari, I M Maisonneuve, S D Glick
Psychopharmacology|December 1, 1996
An oral self-administration model of nicotine preference in rats: effects of mecamylamineS D Glick, K E Visker, I M Maisonneuve
European Journal of Pharmacology|October 27, 1998
Effects of cyclazocine on cocaine self-administration in ratsS D Glick, K E Visker, I M Maisonneuve
European Journal of Pharmacology|June 28, 1991
Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis studyI M Maisonneuve, R W Keller, S D Glick
Brain Research|May 11, 1992
Interactions of ibogaine and D-amphetamine: in vivo microdialysis and motor behavior in ratsI M Maisonneuve, R W Keller, S D Glick
Pharmacology, Biochemistry, and Behavior|July 27, 1999
Ibogaine enhances the expression of locomotor sensitization in rats chronically treated with cocaineK K Szumlinski, I M Maisonneuve, S D Glick
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Brain Research|May 4, 2000
The potential anti-addictive agent, 18-methoxycoronaridine, blocks the sensitized locomotor and dopamine responses produced by repeated morphine treatmentK K Szumlinski, I M Maisonneuve, S D Glick
Toxicon : Official Journal of the International Society on Toxinology|August 11, 2000
Iboga interactions with psychomotor stimulants: panacea in the paradox?K K Szumlinski, I M Maisonneuve, S D Glick
Neuroreport|July 7, 2000
18-MC reduces methamphetamine and nicotine self-administration in ratsS D Glick, I M Maisonneuve, H A Dickinson
Drug and Alcohol Dependence|November 21, 2001
Biphasic dose-related effects of morphine on dopamine releaseI M Maisonneuve, L M Warner, S D Glick
Brain Research|October 21, 1996
Ibogaine neurotoxicity: a re-evaluationH H Molinari, I M Maisonneuve, S D Glick
Psychopharmacology|December 1, 1996
An oral self-administration model of nicotine preference in rats: effects of mecamylamineS D Glick, K E Visker, I M Maisonneuve
European Journal of Pharmacology|October 27, 1998
Effects of cyclazocine on cocaine self-administration in ratsS D Glick, K E Visker, I M Maisonneuve
European Journal of Pharmacology|June 28, 1991
Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis studyI M Maisonneuve, R W Keller, S D Glick
Brain Research|May 11, 1992
Interactions of ibogaine and D-amphetamine: in vivo microdialysis and motor behavior in ratsI M Maisonneuve, R W Keller, S D Glick
Pharmacology, Biochemistry, and Behavior|July 27, 1999
Ibogaine enhances the expression of locomotor sensitization in rats chronically treated with cocaineK K Szumlinski, I M Maisonneuve, S D Glick
Pageof 6